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SUMMARY
Background
Oesophageal squamous cell carcinoma (OSCC) is associated with alcohol
use, tobacco use and African or Asian descent. However, little is known
about how racial background modiﬁes the effects of alcohol or tobacco.
Aim
To investigate how racial and geographical background modiﬁes the effect
of alcohol and tobacco on OSCC via a systematic review and meta-analysis
of published literature.
Methods
We performed a literature search in multiple online databases regardless of lan-
guage. Eligible studies were population-based assessments of the effect of
tobacco and/or alcohol on the risk of OSCC allowing stratiﬁcation by race. The
quality of studies was assessed by the Newcastle-Ottawa Scale. Meta-analyses
were performed to estimate summary effects using random effect models.
Results
Systematic review identiﬁed 9668 unique citations of which 34 were eligible.
The majority were of high quality. The effect of current smoking vs. never-
smoking was weaker among Asians than among Europeans [European:
odds ratio (OR) = 4.21, 95% conﬁdence interval (CI) 3.13, 5.66; Asian:
OR = 2.31, 95% CI 1.78, 2.99], with the 95% CIs not crossing, indicating
statistical signiﬁcance. Asians also trended towards weaker effects of long-
duration cigarette use and of heavy daily cigarette use. There was no differ-
ence in the effect of alcohol on OSCC risk by race.
Conclusions
Contrary to our hypothesis, a weaker effect of tobacco for OSCC was observed
among Asians than among Europeans. Differences in other factors must
explain the higher incidence of OSCC among Asians. More studies are needed
to understand the cause of the disparate incidence of OSCC between races.
Aliment Pharmacol Ther 2013; 38: 1145–1155
ª 2013 John Wiley & Sons Ltd 1145
doi:10.1111/apt.12514
Alimentary Pharmacology and Therapeutics
INTRODUCTION
Oesophageal carcinoma is a disease with signiﬁcant
worldwide impact, accounting for the ﬁfth and ninth
highest cause of mortality due to malignancy in men
and women respectively.1 The two main histological
types of oesophageal cancer are oesophageal adenocarci-
noma (OAC) and oesophageal squamous cell carcinoma
(OSCC). Multiple studies have identiﬁed risk factors for
development of OSCC, the two most notable of which
are exposure to alcohol and tobacco.2–5 These two fac-
tors, in addition to low consumption of fruits and vege-
tables, account for over 90% of OSCC cases.2, 6
For unclear reasons, the incidence of OSCC among
African Americans within the United States (9.4 per
100 000) is signiﬁcantly higher compared with their
white counterparts (2.1 per 100 000).7, 8 Similarly, the
incidence in Asian American men (3.7 per 100 000) and
in Hispanic men (2.6 per 100 000) is greater than among
whites. Globally, the incidence of OSCC is highest in
African and East Asian countries and lowest in European
countries.9 Social demographics such as low income may
contribute to racial differences in the prevalence of
OSCC.10, 11 Furthermore, among individuals with similar
exposures to risk factors, oesophageal cancer susceptibil-
ity may differ due to polymorphisms in enzymes that
metabolise carcinogens.12, 13 For instance, in 40–50% of
Asians, aldehyde dehydrogenase (ALDH2) has low activ-
ity due to a single-nucleotide polymorphism that con-
tributes to elevated blood levels of acetaldehyde (a
known carcinogen) following alcohol consumption.14–16
We hypothesised that individuals of African or Asian
descent have increased susceptibilities to the effects of
tobacco and alcohol on the risk of OSCC compared with
those of European descent. We aimed to synthesise the
available data across multiple studies to better estimate
the association between alcohol and tobacco with OSCC
and how this risk is modiﬁed by race.
MATERIALS AND METHODS
Study protocol
We performed a systematic literature search in MED-
LINE (1948 to February 2013), EBM reviews (ACP Jour-
nal Club, Cochrane Central Register of Controlled Trials,
Cochrane Database of Systematic Reviews, Database of
Abstracts of Reviews of Effects, Cochrane Methodology
Registry, Health Technology Assessment, NHS Economic
Evaluation Database; to February 2013), EMBASE (1947
to June 2011), ISI Web of Knowledge (to February 2013)
and BIOSIS preview (1926 to February 2013) to identify
studies estimating the risk of OSCC in relation to the
use of alcohol and tobacco without regard to language of
the publication. No authors were contacted for any fur-
ther study results.
Key index terms for our literature review included
{esophageal carcinoma, esophageal neoplasm or [esopha-
gus and (squamous cell carcinoma, carcinoma, cancer,
neoplasms, adenosquamous carcinoma or basosquamous
carcinoma)]} and (risk factors, tobacco, tobacco smoke-
less, tobacco use disorder, tobacco smoke pollution,
smoke, smoking, marijuana smoking, cigarette, cigar,
alcohols, alcohol, alcohol drinking, alcoholism, alcohol
abuse, ethanol, alcoholic beverages, liquor, beer, wine,
spirits, or alcoholic intoxication), also using the alterna-
tive spelling ‘oesophageal’ or ‘oesophagus’.
Study selection and data extraction
The studies met inclusion criteria if the following were sat-
isﬁed: (i) The diagnosis of OSCC was based on histology or
was reported only as oesophageal cancer, but was from a
region where OSCC is endemic and OAC very rare (i.e.
Africa or Asia), (ii) smoking and/or alcohol status was
ascertained, (iii) data were stratiﬁed by race and/or reported
from a racially homogenous population, (iv) data presented
as odds ratios (ORs), relative risks (RRs) or hazard ratios
(HRs) or in a format from which the OR or RR could be
calculated, (v) studies were either cohort or case–control
population-based studies, and (vi) study subjects were
unique to that publication. No studies were excluded based
on sample size. Hospital-based studies were excluded unless
the controls were drawn from the community and the hos-
pital(s) was/were the only centre serving that population.
Study references and citations were collected in Endnote
software application version X4 (Thomson Reuters, New
York, NY, USA) with duplicate publications removed.
Two investigators (A.P. and K.O.) reviewed all titles, and
of those that appeared eligible, both investigators indepen-
dently reviewed the abstracts to assess eligibility with con-
ﬂicts resolved by the third author (J.R.). A data collection
form was designed in Microsoft Access 2010 (Microsoft,
Redmond, WA, USA). Abstracts, and if deemed appropri-
ate, full articles, were translated into English as needed.
For abstracts that appeared eligible on ﬁrst review, both
investigators independently abstracted data from the full
articles. After all the data were abstracted, both investiga-
tors then compared and conﬁrmed by consensus to
account for entry error. The database collected information
on study design, country of origin, sex distribution and
summary measures for participants with and without
OSCC based on various levels of tobacco and/or alcohol.
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Strata of exposure varied among studies and needed to
be harmonised across studies for meta-analysis. We
reviewed eligible studies to identify those strata that were
most often and consistently reported. Data were harmon-
ised as best able based on the predominant breakdown of
the studies using three sets of categories for tobacco use,
and one for alcohol use, each with three strata. The clas-
siﬁcations for tobacco use were: (i) ever-smokers (never,
former and current), (ii) average daily cigarette exposure
(never, <20 cigarettes per day, ≥20 cigarettes per day)
and (iii) duration of cigarette use (never, <20 years,
≥20 years of smoking). Alcohol use was classiﬁed into
average weekly use (0, <200 g/week, ≥200 g/week of
alcohol). The mass of alcohol consumption was either
directly reported or, if not, was converted based on the
average alcohol content per drink based on the country
of origin of the study. Reports on the duration of alcohol
usage was limited to eight total studies of which four
were from Asia and three were from Europe, and thus
this was not assessed. Similarly, current vs. former use
was only assessed in three total studies.
Where data were available for the harmonised strata,
a maximally adjusted effect measure was abstracted as
well as a calculated crude effect measure. When a greater
number of strata were used in a study, ORs and
conﬁdence intervals were tabulated and grouped into the
appropriate harmonised stratum. Additionally, when a
stratum reported in a study crossed the harmonised
strata deﬁned in this study, the cases and controls were
moved to either the lower or higher stratum based on
the similarity of that stratum’s magnitude of effect (e.g.
OR) with the corresponding lower or higher stratum
from that study. In both of these cases, a meta-analysis
was performed of the study-reported adjusted ORs to
report a single adjusted OR for our stratum to be used
in the subsequent meta-analysis across studies.
Study quality criteria
Study quality was assessed by use of the Newcas-
tle-Ottawa Scale.17, 18 This scale measures the quality of
studies on a scale of 0–9 via the assessment of three
main domains: selection of study groups, comparability
of groups and ascertainment of exposure. Quality was
assessed in duplicate (A.P. and K.O.) and discrepancies
were resolved by consensus. All studies that met the
initial eligibility criteria were included in the initial
meta-analysis; subgroup analysis was subsequently per-
formed stratifying by study quality. Those studies that
achieved a score of 9 were deemed ‘highest quality’ for
the subgroup analysis.
Analysis
Meta-analyses were conducted to estimate the summary
OR using MIX 2.0 Pro software (Leon Bax, Kanagawa,
Japan).19 Meta-analyses were conducted for each of the
four exposure categorisations (three for tobacco and one
for alcohol), separately for the abstracted crude effects
and for maximally adjusted effects, using inverse vari-
ance. Heterogeneity of the pooled estimate was tested
with the Cochrane’s Q statistic, with a P-value <0.10
considered as indicating heterogeneity. The inconsistency
index (I2) was used to estimate the degree of heterogene-
ity; the low, moderate and high degrees of heterogeneity
correlated with I2 values of 25%, 50% and 75% respec-
tively.20 Where HR or RR was reported, we assumed that
this closely approximated the OR. All summary ORs are
reported from random-effect models. Heterogeneity of
results can reﬂect differences in study design or effect
modiﬁcation across strata of outcomes. Resolution of
heterogeneity was the primary test for difference in esti-
mates. Heterogeneity might be resolved by performing a
series of pre-determined stratiﬁed analyses, thereby iden-
tifying strata with homogeneous results with more reli-
able estimates of the effects of exposure within those
strata than the estimates for effects in all of the studies
combined. We a priori planned to conduct analyses
stratiﬁed by continent of origin for the population stud-
ied. In all but two studies, the continent of origin was
identical to the continent of residence. In one study from
the United States, the data could be stratiﬁed into those
of European descent (i.e. whites) and those predomi-
nantly of African descent (i.e. African Americans). We
also planned analyses restricted to the highest quality
studies. Given the substantial heterogeneity found in the
analyses, the potential for dissemination bias was not
assessed, as methods for their assessment are inaccurate
in the setting of substantial heterogeneity.21
RESULTS
Our initial database search identiﬁed 9668 citations (Fig-
ure 1). Following removal of duplicates, 7629 abstracts
were assessed and 411 articles appeared to be appropri-
ate for review. The full-text papers of these 411 citations
were reviewed and 34 studies met eligibility requirements
for inclusion (Table 1).6, 22–54
Study characteristics
Of the 34 eligible citations, 13 studies provided data on
individuals of European (including 1 from Australia), 14
of Asian, 5 of South American and 2 of African descent.
One of the studies6 contained data on both Caucasians
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and African Americans, so the study was included twice.
Twenty-ﬁve were case–control and 9 were cohort studies;
28 studies included data on smoking status (never, for-
mer or current), 22 included data on daily cigarette use
and 13 included data on smoking duration. Alcohol con-
sumption was reported in 18 of the studies.
The forest plots for the maximally adjusted effects of
tobacco and alcohol on the risk of OSCC are shown in Fig-
ures S1–S4, comparing maximal exposure vs. no exposure.
The maximally adjusted OR for alcohol consumption of
greater than 200 g/week was 4.65 [95% conﬁdence interval
(CI) = 3.61, 5.99], but the results were heterogeneous
(Q = 15.75, P = 0.03, I2 = 56%). The maximally adjusted
OR for exposure to tobacco by current smokers vs. never
smokers was 3.13 (95% CI = 2.53, 3.86). For greater than
20 cigarettes per day vs. nonsmokers, the maximally
adjusted OR was 3.66 (95% CI = 2.73, 4.90). The maximally
adjusted OR for a smoking duration of greater than
20 years vs. nonsmokers was 2.81 (95% CI = 2.06, 3.83).
The results for tobacco exposure were each very hetero-
geneous with I2 values between 86% and 87% as demon-
strated in Table S1. Dose–response relationships were found
for each classiﬁcation of alcohol and tobacco use (Table S2).
Analyses restricted to highest study quality or
stratiﬁed by design
Table S1 shows the summary ORs for alcohol and
tobacco when maximally adjusted estimates and
estimates from only the highest quality studies (scoring 9
out of 9 possible points on the Newcastle-Ottawa Index)
were used. The summary maximally adjusted estimate
for consuming >200 g/week of alcohol was lower when
the analysis was restricted to the highest quality studies
(OR = 3.49; 95% CI = 2.82, 4.32), and heterogeneity was
resolved (Q = 7.94, P = 0.16, I2 = 37%). Those studies
included four from East Asia, one from India and one
from Europe. The estimated effects of tobacco use in the
highest quality studies were comparable to the estimates
from the entire set of studies, and the results remained
heterogeneous (I2 range: 86–89%). When the studies
were stratiﬁed by design (case–control vs. cohort), there
were greater effect estimates for each exposure in the
case–control studies than in the cohort studies, but still
with substantial heterogeneity (Table S3).
Stratifying by race
Table 2 shows the results for analyses stratiﬁed by conti-
nent of origin, which was the primary objective of this
study. For current tobacco use, the summary OR for the
risk of OSCC vs. never use in Europeans was 4.21 (95%
CI = 3.13, 5.66), compared to lower values in Asians
and South Americans [2.31 (95% CI = 1.78, 2.99) and
3.29 (95% CI = 1.75, 6.18) respectively]. Of particular
note, the effect of current tobacco vs. never use was
nearly twice as strong among Europeans than among
Asians, with the 95% CIs not overlapping, indicating a
statistically signiﬁcant difference. For daily use of more
than 20 cigarettes vs. never smokers, the summary ORs
were 4.42 (95% CI = 3.23, 6.06) for Europeans and 2.52
(95% CI = 1.78, 3.57) for Asians. For duration of
smoking more than 20 years vs. never smokers, the
summary ORs were 3.31 (95% CI = 2.15, 5.10) for
Europeans and 2.34 (95% CI = 1.57, 3.50) for Asians.
Notably, for all three categories of tobacco quantiﬁcation
(ever usage, daily exposure, and duration of usage), the
summary OR for developing OSCC was higher for
Europeans than for Asians. However, there was still
substantial heterogeneity in each stratum for all effect
estimates. When we further categorised our analysis by
sub-continent to compare Southern Europe (including
Iran) to Eastern Asia, there was an overall trend for a
higher adjusted OR amongst the Southern European
countries (Table S4). However, again, the results were
heterogeneous.
Records screened after
duplicates removed
(n = 7629)
Full-text articles
assessed for eligibility
(n = 411)
Full-text articles
excluded
(n = 377)
Records excluded
(n = 7218)
Studies included in
quantitative synthesis
(meta-analysis)
(n = 34)
Records identified
through database
searching
(n = 9668)
Figure 1 | Flow chart of literature search, selection, and
analysis.
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For weekly consumption of more than 200 g of alco-
hol vs. never drinkers, the summary ORs were 5.05 (95%
CI = 3.40, 7.49) for Asians and 3.42 (95% CI = 2.29,
5.09) for Europeans. There was no difference in the
effects of alcohol on the risk of OSCC across continents
of origin. Due to the small number of studies of African
populations (n = 2), meta-analyses could not be per-
formed for that stratum.
DISCUSSION
To our knowledge, this is the ﬁrst systematic review and
meta-analysis estimating the effects of alcohol and tobacco
on the risk of OSCC among different populations based on
race and geographical location. As African Americans and
Asian Americans are at greater risk of OSCC than white
Americans, we had hypothesised that the effects of alcohol
and tobacco on the risk of OSCC would be greater among
individuals of Asian or African descent than among those of
European descent due to genetic factors. A recent Italian
study evaluated 30 single-nucleotide polymorphisms involved
in metabolising alcohol, acetaldehyde and tobacco-related
carcinogens. Four were signiﬁcantly associated with risk of
upper aerodigestive tract cancer: cytochrome P450 (CYP)
enzymes CYP1A1 and CYP2A6, gluthathione 6-transferase
(GSTA2) and alcohol dehydrogenase (ADH1C). CYP
enzymes are involved in tobacco metabolism, and efﬁciency
in the conversion of ethanol to acetaldehyde, and subsequent
oxidation to acetate, is mainly driven by the alcohol dehydro-
genase (ADH) and ALDH gene families.13 A polymorphism
of ADH1C has been associated with an increased risk of
upper aerodigestive tract cancers.13 In 40–50% of Asians,
ALDH2 has low activity due to a single-nucleotide polymor-
phism that contributes to elevated blood levels of acetalde-
hyde following alcohol consumption.12, 16
This study conﬁrmed the expected dose-dependent
relationship between both alcohol and tobacco with the
risk of OSCC. Strong associations were found regardless
of study quality and in all races, but the results of nearly
all analyses were very heterogeneous. Contrary to our
hypothesis, we did not ﬁnd any substantial differences in
the effect of alcohol on the risk of OSCC based on race.
We were also surprised to discover a statistically signiﬁ-
cant weaker effect of tobacco for OSCC among Asians
than among Europeans, as the 95% conﬁdence intervals
for current smokers vs. never smokers did not overlap.
As there is relatively less regulation of carcinogen con-
tent in tobacco in Asian countries than in European
countries, this ﬁnding is even more striking.55 In addi-
tion to a true ﬁnding, there are a few possible other
explanations for this ﬁnding. First, there may have been
residual misclassiﬁcation of smoking status by the dura-
tion and intensity of tobacco use. Although the effects of
smoking duration and smoking intensity appeared stron-
ger among Europeans than among Asians, the 95% con-
ﬁdence intervals overlapped, and the heterogeneity of
those effect estimates were not resolved by stratifying by
race. If European smokers, on average, smoke a greater
quantity and for a longer duration than Asians, the effect
of current smoking might appear stronger among Euro-
peans than among Asians. The ﬁnding could also reﬂect
a time-lag between commencement of smoking and dis-
ease onset; for instance, in countries such as China
where smoking did not reach its peak popularity until
the mid-1990s, the full impact of tobacco may not yet
have been realised in published studies.56, 57 In addition,
there may be differences in smoking behaviours across
cultures, including depth and frequency of inhalation.
Finally, given the substantial heterogeneity in results
across studies, even within strata of races, the differences
between races may reﬂect differences in study designs.
If differences in the effects of alcohol and tobacco do not
explain the greater incidences of OSCC among Asian
American and African Americans than white Americans,
then what does? The differences might still be explained by
a higher prevalence of heavy use in those populations com-
pared with whites. Although our study attempted to har-
monise similar quantities of alcohol and tobacco use across
different population-based studies, amounts used were gen-
erally presented in broad categories and speciﬁc types of
alcohol were not taken into account. Studies have also indi-
cated an increased risk of OSCC with speciﬁc types of alco-
hol including home-brewed, moonshine whiskey and hard
liquor, use of both of which is found to be more common
in African Americans.5 Lower socioeconomic status and
less education have also been identiﬁed as factors that
might explain the racial disparity within the United
States.11 Differences in consumption of fruits and vegeta-
bles may also play a role. Engel et al. demonstrated in a
population-based study that almost 90% of the cases of
OSCC could be accounted for by smoking, alcohol con-
sumption or low consumption of fruits and vegetables
among the American population studied; low fruit and veg-
etable consumption alone accounted for 20% of OSCC.2
Additional studies are needed to conﬁrm those ﬁndings.
Furthermore, it is well understood that OSCC has a
geographical prevalence that may not limit itself to con-
tinents as we have deﬁned in our study. There is indeed
an oesophageal cancer belt that extends from Iran to
central China.58, 59 When we further categorised our
analysis by sub-continent to compare Southern Europe
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Table 1 | Studies included in the meta-analysis (to be read in conjunction with the following three pages)
Author Year
Reference
#
Country/
region
Continent
of origin Study type
% cases
male
% controls
male
Allen 2009 22 United Kingdom Europe Prospective cohort 0 0
Bahmanyar 2006 23 Sweden Europe Case–control 72 83
Brown 1994 6 USA Europe, Africa Case–control 100 100
De Stefani 1990 24 Uruguay South America Case–control 76 76
De Stefani 2008 25 Uruguay South America Case–control 79 79
Fan 2008 26 China Asia Prospective cohort 100 100
Gallus 2003 27 Italy, Switzerland Europe Case–control 82 82
Gallus 2001 28 Italy, Switzerland Europe Case–control 0 0
Ganesh 2009 29 India Asia Case–control 64 53
Garidou 1996 30 Greece Europe Case–control 65 72
Gledovic 2007 31 Serbia Europe Case–control 85 85
Hanaoka 1994 32 Japan Asia Case–control 100 100
Ishiguro 2009 33 Japan Asia Prospective cohort 100 100
Kimm 2010 34 Korea Asia Prospective cohort 100 100
Lagergren 2000 35 Sweden Europe Case–control 72 83
Menezes 2002 36 Brazil South America Case–control 81 81
Nasrollahzadeh 2008 37 Iran Asia Case–control 50 49
Pandeya 2008 39 Australia Australia Case–control
Sharp 2001 38 UK Europe Case–control 0 0
Steevens 2010 40 Netherlands Europe Prospective cohort 55 49
Sun 2004 41 Korea Asia Prospective cohort 100 100
Szymanska 2011 42 Brazil, Argentina, Cuba South America Case–control 81 79
Tai 2010 43 Taiwan Asia Case–control 0 0
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Tobacco use quantiﬁcation
Alcohol
quantiﬁed by
weekly use Factors controlled for
Newcastle-Ottawa
Scale for Quality
Ever
use
Daily quantity
used
Duration
of use
   + Age, tobacco use, obesity, physical
activity, region of residence,
socioeconomic status, use of oral
contraceptives, and hormone
replacement therapy
8
+     8
+ +   Age, tobacco use, alcohol use,
geography, income
9
   + Age, tobacco use, alcohol use, residence 8
+    Age, sex, tobacco use, obesity, total
energy intake, residence (urban/rural),
birthplace, education, family history of
oesophageal cancer
8
+ +  + Alcohol use, obesity, summed intakes of
preserved foods, fresh fruits and
vegetables, education
9
+ + +  Age, sex, alcohol use, study centre,
education
8
+ +  + Education, obesity, non-alcohol use
energy intake, tobacco use, alcohol use
8
  +  Age, sex, residence, occupation 7
 +  +  8
+     8
+   +  7
+ +  + Age, alcohol use, obesity, preference for
hot foods and drinks, region of
residence, ﬂushing response
9
+ +  + Age, alcohol use, obesity, exercise,
aspartate aminotransferase levels
9
+ + + + Age, sex, tobacco use, obesity, energy
intake and physical activity, intake of
fruit and vegetables, educational level,
reﬂux symptoms
8
+    Alcohol use, race, vitamin consumption,
region of residence, education,
household pollution, lung cancer,
profession
7
+ + +  Education, ethnicity 8
+ + +  Age, sex, alcohol use, obesity, education,
aspirin use, frequency of GERD
7
+  + + Diet, tobacco use, regular use of aspirin,
temperature of tea/coffee
7
+ +  + Age, sex, tobacco use, alcohol use,
obesity, energy intake, food
consumption, education
9
+    Age 9
+ + + + Age, sex, tobacco use, alcohol use, fruit
and cruciferous consumption, enrolment
centre, education
7
+   + Age, tobacco use, alcohol use, tea
consumption, areca chewing, education
9
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(including Iran) with Eastern Asia, our results were simi-
lar showing a greater effect of tobacco among East
Asians than among Southern Europeans.
There are some important limitations to this study.
First is the relative paucity of studies regarding African
populations. The majority of the studies identiﬁed in Afri-
can populations were either not methodologically speciﬁc
enough or did not classify exposures in the appropriate
strata. We had hoped to compare the effects of exposure
in Africans vs. African Americans. However, many of the
US-based studies, although containing a signiﬁcant num-
ber of African American subjects, did not provide data
stratiﬁed by race and thus most of those studies were not
included. The one study from Africa conﬁrmed an overall
increased trend towards OSCC in African men who were
exposed to tobacco as well as those who consumed a diet
low in micronutrients such as zinc, magnesium and ribo-
ﬂavin.45 Similarly, the study assessing racial trends in Afri-
can Americans found a higher incidence of OSCC in
African American men for the same level of alcohol and
tobacco use, with a 14.9 per 100 000 more cases of OSCC
in African American men compared with white men for
the same exposure of alcohol and tobacco.
Similarly, sex-speciﬁc analyses could not be reported,
as most studies did not separate out the incidence based
on sex, instead reporting overall prevalence of each sex
in the population. Furthermore, the pooled alcohol- and
tobacco-related risk for OSCC was calculated using stud-
ies that met the pre-deﬁned criteria, notably ones that
were stratiﬁed by race. As such, the summary estimates
for all races with regard to alcohol and tobacco may not
reﬂect estimates from the entire set of publications on
this topic. Importantly, heterogeneity was not explained
by stratifying by race, so it is possible that the ﬁnding of
weaker effects of smoking in Asians than Europeans is
not true. We chose our protocol for harmonising strata
of exposures to improve the precision of effect estimates,
but it could have introduced bias in those estimates.
Additionally, as not all studies reported data on each
outcome of interest, our estimates of the effects might be
biased in an unpredictable direction. Finally, recall bias
may have affected the results of case–control studies as
patients and or family members were asked to estimate
alcohol or tobacco use after development of OSCC.
Strengths of the study include the exhaustive literature
search including for articles in non-English languages,
the overall high quality of the studies included, and the
pre-speciﬁed plan for stratiﬁed analyses.
In summary, the effect of tobacco on the risk of
OSCC appears to be weaker among Asians than among
Europeans, without a difference in the effect of alcohol,
but the results from different studies are very hetero-
Table 1 | (Continued)
Author Year
Reference
#
Country/
region
Continent
of origin Study type
% cases
male
% controls
male
Tran 2005 44 China Asia Prospective cohort 49 45
Van Rensburg 1985 45 South Africa Africa Case–control 100 100
Vassallo 1985 46 Uruguay South America Case–control 100 100
Vioque 2008 47 Spain Europe Case–control 93 63
Wang 2007 48 China Asia Case–control 100 100
Wu 2006 49 Taiwan Asia Case–control 100 100
Yang 2005 50 China Asia Case–control 64 64
Yun 2004 51 Korea Asia Prospective cohort 100 100
Zambon 2000 52 Italy Europe Case–control 100 100
Zendehdel 2008 53 Sweden Europe Prospective cohort 100 100
Znaor 2003 54 India Asia Case–control 100 100
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geneous. As such, it appears that Asian race may mod-
ify the risk of tobacco for the development of OSCC.
However, given the heterogeneity of the estimates,
future studies are needed both to explain this ﬁnding
and to examine for differential effects in individuals of
African descent.
AUTHORSHIP
Guarantor of the article: The guarantor of this work and
its integrity is Joel Rubenstein, MD, MSc.
Author contributions: All authors listed contributed
equally to the study design, data collection, review,
analysis and manuscript preparation and submission.
Tobacco use quantiﬁcation
Alcohol
quantiﬁed by
weekly use Factors controlled for
Newcastle-Ottawa
Scale for Quality
Ever
use
Daily quantity
used
Duration
of use
+ + +  Age, sex, tobacco use, ﬁrst-degree relatives
with OSCC
9
+    Age, tobacco use, diet 7
 +   Age 6
+ + + + Age, sex, tobacco use, alcohol use, energy-
adjusted intake of fruit and vegetables,
province inhabited, education
7
+ +   Age, tobacco use, alcohol use, dietary
habits, green tea drinking history, marital
status, education
8
+ + + + Age, alcohol use, tobacco use, betel-quid
chewing, level of education, occupation.
7
 +  + Tobacco use, alcohol use, diet, family history
of oesophageal cancer, occupation
7
+ + +  Age, alcohol use, obesity, physical activity,
diet, place of residence
9
+ + + + Age, tobacco use, alcohol use, area of
residence, education
7
+    Age, obesity 9
+  + + Age, tobacco use, alcohol use, enrolment
centre, education level
9
Table 2 | Racial differences in the summary associations of alcohol and tobacco use with oesophageal squamous cell
carcinoma
Exposure Race/continent
Number
of studies
Summary
adjusted OR
Conﬁdence interval
Lower limit Upper limit Q P-value I2 (%)
Current tobacco
use vs. never
All 29 3.13 2.53 3.86 213.38 <0.001 87
Asia 12 2.31 1.78 2.99 79.02 <0.001 86
Europe 12 4.21 3.13 5.66 37.91 <0.001 71
South America 3 3.29 1.75 6.18 4.57 0.10 56
>20 cigarettes
daily vs. never
All 21 3.66 2.73 4.90 144.97 <0.001 86
Asia 9 2.52 1.78 3.57 42.72 <0.001 81
Europe 9 4.42 3.23 6.06 20.26 <0.002 61
>20 years of
smoking vs. never
All 13 2.81 2.06 3.83 90.65 <0.001 87
Asia 6 2.34 1.57 3.50 48.85 <0.001 90
Europe 6 3.31 2.15 5.10 11.45 <0.05 56
>200 g of alcohol
per week vs. never
All 18 4.65 3.61 5.99 57.99 <0.001 71
Asia 8 5.80 3.64 9.24 51.83 <0.001 77
Europe 8 3.87 2.57 5.82 15.75 <0.003 56
OR, odds ratio; Q, Cochrane’s Q; I2, inconsistency index.
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